Skip to main content
Home
FULL MENU Close Menu
Home
Home

Caleb Rans

News

ASCO clinical practice guideline update incorporates Oncotype DX

Author:
Caleb Rans
Publish date: June 4, 2019

In women with hormone receptor–positive, axillary node–negative breast cancer with Oncotype DX recurrence scores of less than 26, there is minimal...

  • Read More

News

NCCN publishes pediatric ALL guidelines

Author:
Caleb Rans
Publish date: June 3, 2019

While treatment for ALL often includes long-term chemotherapy regimens, various types of immunotherapy and targeted therapy are also summarized in...

  • Read More

News

Cediranib may alter DNA repair capacity

Author:
Caleb Rans
Publish date: June 3, 2019

The preclinical finding may have implications for the development of combination treatment with olaparib for cancer patients.

  • Read More

News

Novel anti-PD-1 antibody can be given subcutaneously

Author:
Caleb Rans
Publish date: May 31, 2019

“Subcutaneous administration of an anti-PD-1 antibody in patients with advanced solid tumors appears to be feasible,” the investigators wrote.

  • Read More

News

Revascularization plus exercise is most effective for intermittent claudication

Author:
Caleb Rans
Publish date: May 29, 2019

Percutaneous transluminal angioplasty plus supervised treadmill exercise therapy could be a first-line treatment...

  • Read More

News

Genetic analysis identifies prognostic markers in CLL

Author:
Caleb Rans
Publish date: May 28, 2019

A single 11q22 deletion, lacking an ATM mutation on the other allele, had the shortest progression-free survival among patients with CLL who were...

  • Read More

News

FVIII/W ratio may help predict relapse in hemophilia A

Author:
Caleb Rans
Publish date: May 22, 2019

The biological marker was the first indication of relapse in most patients who relapsed during the study period.

  • Read More

News

Novel chromogenic assay looks accurate in hemophilia A diagnosis

Author:
Caleb Rans
Publish date: May 22, 2019

The BIOPHEN FVIII:C assay had limited variation and performed well when compared with a one-stage clotting assay and another chromogenic assay,...

  • Read More

News

Low-dose FVIII prophylaxis reduced bleeding in hemophilia A

Author:
Caleb Rans
Publish date: May 22, 2019

Low-dose prophylaxis with factor VIII outperformed on-demand treatment in children with severe hemophilia A. The findings have implications for...

  • Read More

News

Family history plays a large role in bleeding disorder diagnosis in women

Author:
Caleb Rans
Publish date: May 17, 2019

The survey of women with congenital bleeding disorders in Europe highlighted delays in diagnosis and burdens on activities of daily living.

  • Read More

News

CD23 expression linked to improved survival in MCL

Author:
Caleb Rans
Publish date: May 17, 2019

Researchers found that mantle cell lymphoma cases that were CD23 positive had a higher frequency of leukemic nonnodal presentation and CD200...

  • Read More

News

Literature review shows inconsistent measurement of financial toxicity

Author:
Caleb Rans
Publish date: May 16, 2019

Systematic review reveals lack of validated instruments to effectively measure the financial burden experienced by cancer patients.

  • Read More

News

Younger patients with NSCLC tend to live longer

Author:
Caleb Rans
Publish date: May 15, 2019

According to a retrospective analysis, younger patients with NSCLC had better survival, despite higher rates of brain metastasis and drive...

  • Read More

News

Most postapproval trials explore novel indications

Author:
Caleb Rans
Publish date: May 10, 2019

Among 600 post-approval studies, only 12.0% solely examined the original therapeutic indication.

  • Read More

News

Study finds lower quality of life for patients with hemophilia A

Author:
Caleb Rans
Publish date: May 9, 2019

Patients with hemophilia A reported lower health-related quality of life even though they were receiving standard treatment.

  • Read More

Pages

  • « first
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close